Carl Zeiss Meditec AG (ETR:AFX) has been given a €40.00 ($47.06) price objective by equities researchers at Deutsche Bank AG in a research report issued on Tuesday. The brokerage presently has a “neutral” rating on the stock.

A number of other equities analysts have also recently issued reports on AFX. Berenberg Bank set a €48.00 ($56.47) price objective on shares of Carl Zeiss Meditec AG and gave the stock a “buy” rating in a research report on Saturday, May 20th. Independent Research GmbH set a €44.00 ($51.76) price objective on shares of Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a research report on Saturday, May 20th. Kepler Capital Markets set a €48.50 ($57.06) price objective on shares of Carl Zeiss Meditec AG and gave the stock a “buy” rating in a research report on Saturday, May 20th. Commerzbank Ag set a €42.00 ($49.41) price objective on shares of Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a research report on Saturday, May 20th. Finally, Nord/LB set a €52.00 ($61.18) price objective on shares of Carl Zeiss Meditec AG and gave the stock a “buy” rating in a research report on Friday, June 2nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company’s stock. Carl Zeiss Meditec AG presently has a consensus rating of “Hold” and a consensus price target of €45.75 ($53.82).

Shares of Carl Zeiss Meditec AG (AFX) opened at 44.676 on Tuesday. Carl Zeiss Meditec AG has a one year low of €30.80 and a one year high of €47.80. The company has a 50 day moving average of €45.47 and a 200-day moving average of €42.31. The firm has a market cap of €4.00 billion and a price-to-earnings ratio of 32.492.

TRADEMARK VIOLATION NOTICE: “Carl Zeiss Meditec AG (ETR:AFX) Given a €40.00 Price Target at Deutsche Bank AG” was reported by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.americanbankingnews.com/2017/08/08/carl-zeiss-meditec-ag-etrafx-given-a-40-00-price-target-at-deutsche-bank-ag.html.

Carl Zeiss Meditec AG Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery.

Analyst Recommendations for Carl Zeiss Meditec AG (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.